Heather
Heather Aeder, Flourtown, PA US
Patent application number | Description | Published |
---|---|---|
20090094056 | Systems And Methods For Projecting Sample Store Activities That Are Restricted In Non-Sample Stores - Systems and methods are provided for estimating non-sampled store activities by applying projection factors to sampled store activities taking into account restrictions on non-sampled store activities. The systems and methods adjust data projection factors for managed healthcare plans that have restrictions in non-sampled stores to prevent unrestricted activity under these plans at sample stores from being projected into non-sample stores where such projected activity would be restricted. Conventional sampled-to-non-sampled store projection factors leading to restricted plan activities are reallocated to non-restricted plan activities in the non-sample store based on the historical ratio of such activities observed in sample stores. | 04-09-2009 |
Heather Allderidge, Derby GB
Patent application number | Description | Published |
---|---|---|
20090260355 | Stirling engine assembly - A Stirling engine assembly comprising a Stirling engine ( | 10-22-2009 |
20110025055 | Domestic combined heat and power generation system - A domestic combined heat and power generation system comprising a pair of Stirling engines mounted so that the vibrations of one substantially counteract the vibrations of the other. At least one engine burner heats the heads of the engines. An auxiliary burner provides additional heat. Gas and air are supplied to the engine burner and auxiliary burner controlled by a controller. A heat exchanger recovers heat from the exhaust gases from the engine burner and auxiliary burner and provide a heat output. An electrical output is provided from an alternator of each engine. The engines having a combined electrical power output of less than 2.5 kW. | 02-03-2011 |
Heather Balji, Mahwah, NJ US
Patent application number | Description | Published |
---|---|---|
20140084179 | EXPOSURE CHAMBER AND A SYSTEM FOR REDUCTION OF PATHOGENS IN A BIOLOGICAL FLUID USING ULTRAVIOLET IRRADIATION BY LIGHT EMITTING DIODES - An exposure chamber for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a serpentine-shaped UV-transparent flow path and closely positioned ultraviolet light emitting diodes configured for emanating UV irradiation towards the biological fluid at peak wavelength of 250 nm to 270 nm. The control system is provided to energize UV LEDs using various novel modes of modulating pulse width and current amplitude for LEDs so as to deliver higher UV intensity to the biological fluid but without overheating thereof or the LEDs. | 03-27-2014 |
20140086793 | SYSTEMS AND METHODS FOR REDUCTION OF PATHOGENS IN A BIOLOGICAL FLUID USING VARIABLE FLUID FLOW AND ULTRAVIOLET LIGHT IRRADIATION - A system and method for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by causing the pump to vary the flow of fluid. In embodiments, the pump may be operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time. | 03-27-2014 |
20140091045 | SYSTEMS AND METHODS FOR REDUCTION OF PATHOGENS IN A BIOLOGICAL FLUID USING VARIABLE FLUID FLOW AND ULTRAVIOLET LIGHT IRRADIATION - A system and method for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by causing the pump to vary the flow of fluid. In embodiments, the pump may be operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time. | 04-03-2014 |
20140097353 | SYSTEMS AND METHODS FOR REDUCTION OF PATHOGENS IN A BIOLOGICAL FLUID USING VARIABLE FLUID FLOW AND ULTRAVIOLET LIGHT IRRADIATION - A system for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by a pump control system programmed to cause the pump to vary the flow of fluid. In embodiments, the pump may be automatically operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time. | 04-10-2014 |
Heather Balsiger, El Paso, TX US
Patent application number | Description | Published |
---|---|---|
20120283215 | PHARMACEUTICAL COMPOSITIONS WHICH INHIBIT FKBP52-MEDIATED REGULATION OF ANDROGEN RECEPTOR FUNCTION AND METHODS OF USING SAME - Pharmaceutical compositions that bind to a predicted FK506 Binding Protein 52 (FKBP52) interaction surface on the androgen receptor hormone binding domain, otherwise known as FKBP52 Targeting Agents (FTAs) are provided. These compositions of the present invention are found to specifically recognize the FKBP52 regulatory surface on the androgen receptor and inhibit FKBP52 from functionally interacting with the androgen receptor. Compositions comprising the pharmaceutical composition, as well as methods of use, treatment and screening are also provided. | 11-08-2012 |
Heather Beam-Brennan, Red Bank, NJ US
Patent application number | Description | Published |
---|---|---|
20100016967 | RESORBABLE MEDICAL IMPLANTS AND RELATED METHODS - Biocompatible, resorbable medical implants and related methods are disclosed in which the implant can be made of a collagen matrix for filling a space after partial or total resection of the trapezium bone of the wrist. The resorbable medical implant can include a plurality of surface projections, and the collagen matrix can be folded or spirally wound about itself to form a spiral roll. | 01-21-2010 |
Heather Beck Knowles, Chelmsford, MA US
Patent application number | Description | Published |
---|---|---|
20110071395 | TRANSESOPHAGEAL AND TRANSNASAL, TRANSESOPHAGEAL ULTRASOUND IMAGING SYSTEMS - A semi-invasive ultrasound imaging system for imaging biological tissue includes a transesophageal probe or a transnasal, transesophageal probe connected to a two-dimensional ultrasound transducer array, a transmit beamformer, a receive beamformer, and an image generator. The two-dimensional transducer array is disposed on a distal portion of the probe's elongated body. The transmit beamformer is connected to the transducer array and is constructed to transmit several ultrasound beams over a selected pattern defined by azimuthal and elevation orientations. The receive beamformer is connected to the transducer array and is constructed to acquire ultrasound data from the echoes reflected over a selected tissue volume. The tissue volume is defined by the azimuthal and elevation orientations and a selected scan range. The receive beamformer is constructed to synthesize image data from the acquired ultrasound data. The image generator is constructed to receive the image data and generate images that are displayed on an image display. Preferably, the image generator is constructed to generate, from the image data, several orthographic projection views over the selected tissue volume. | 03-24-2011 |
Heather Behanna, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20100240668 | Myosin Light Chain Kinase Inhibitor Compounds, Compositions and Related Methods of Use - Pyridazinyl compounds, compositions and related methods of use. | 09-23-2010 |
20130029999 | MYOSIN LIGHT CHAIN KINASE INHIBITOR COMPOUNDS, COMPOSITIONS AND RELATED METHODS OF USE - Pyridazinyl compounds, compositions and related methods of use. | 01-31-2013 |
Heather Bell, Creve Coeur, MO US
Patent application number | Description | Published |
---|---|---|
20130274605 | METHOD OF USING A DOPPLER BLOOD FLOW METER SYSTEM HAVING A FLAT PROBE APPARATUS FOR OBTAINING BLOOD FLOW DATA - A method of obtaining blood flow data from an individual using a Doppler blood flow meter system having a main unit in operative communication with a probe apparatus having at least one flat probe configured to be attached to the individual is disclosed. The flat probe has a substantially flat configuration and includes a transmitter transducer for transmitting ultrasound signals and a receiver transducer for receiving reflected Doppler ultrasound signals. The flat probe is configured for attachment to the individual being examined. At least one inflatable cuff in operative communication with the main unit is attached to the individual and the pressure in the inflatable cuff is raised such that the blood pressure of the individual is elevated. The main unit includes a processor that processes the reflected Doppler ultrasound signals received from the flat probe to determine the systolic pressure of the individual. | 10-17-2013 |
Heather Bimonte-Nelson, Phoenix, AZ US
Patent application number | Description | Published |
---|---|---|
20120245188 | METHODS OF TREATING MEMORY LOSS AND ENHANCING MEMORY PERFORMANCE - The present invention provides methods and compositions for enhancing working memory impaired due to aging, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, alcoholism or alcohol withdrawal or Huntington's disease using p38 MAPK inhibitor such as SB239063. | 09-27-2012 |
Heather Cumming Rowell, Weymouth, MA US
Patent application number | Description | Published |
---|---|---|
20100146686 | Disposable Non-Woven, Flame-Resistant Coveralls - A non-woven, flame resistant fabric and a disposable coverall made from the fabric. The non-woven, flame resistant fabric is made of a plurality of NOMEX® synthetic fibers, a plurality of KEVLAR® synthetic fibers, and a plurality of electrostatic dissipative fibers. The coverall has an upper section for covering the shoulder, chest, back and abdominal regions of a wearer. The upper section has long sleeves to cover the arms of the wearer and a collar to cover the neck region of wearer. The coverall also has a waist section contiguous with the upper section for covering the waist region of a wearer, and a pair of leg sections for covering the legs of the wearer. Each leg section has an upper portion contiguous with the waist section. The coverall also has a seat section contiguous with the waist section and the upper portions of the leg sections. The coverall has a two-way zipper extending from the collar section to the waist section. | 06-17-2010 |
Heather Dans, Marshfield, MA US
Patent application number | Description | Published |
---|---|---|
20120132658 | METHOD AND APPARATUS FOR CALIBRATING THERMOMETERS - A calibration device allows accurate and consistent creation of ice baths and aids in the calibration of food safety thermometers. Such devices include a calibration wrench on a cup lid for holding and calibrating a thermometer, a stem thermometer access hole on the cup lid, an insulated cup for holding a substance to be measured, and a liquid crystal reversible temperature label on the cup. | 05-31-2012 |
Heather Degruttola, Newton, NH US
Patent application number | Description | Published |
---|---|---|
20100004175 | NOVEL BMP-12-RELATED PROTEINS AND METHODS OF THEIR MANUFACTURE - The invention provides novel BMP-12-related proteins, including methods of their manufacture. The proteins include substituted, truncated and substituted-truncated BMP-12-related proteins. The substituted BMP-12-related proteins contain a substitution at one or more oxidation-sensitive methionine residues with non-methionine residues, such as norleucine. The substituted BMP-12-related proteins exhibit normal bioactivity and enhanced resistance to oxidation, relative to the unsubstituted protein. The truncated BMP-12-related proteins exhibit enhanced activity. | 01-07-2010 |
Heather Desaire, Lawrence, KS US
Patent application number | Description | Published |
---|---|---|
20090311289 | VACCINE - The present invention relates, in-general, to Human immunodeficiency virus (HIV), and in particular to a carbohydrate-based vaccine for HIV and to methods of making and using same. | 12-17-2009 |
20110105735 | METHODS OF PRODUCING AND PURIFYING PROTEINS - Methods of producing and purifying proteins that comprise a glycan tag are provided. In some embodiments, a protein may be modified to include a glycan tag so as to facilitate production of the protein, e.g., by promoting protein secretion and/or promoting protein solubility. In some embodiments, the present disclosure provides methods wherein a protein may be modified to include a glycan tag, which may then be used as an affinity tag for purification. | 05-05-2011 |
20150050309 | VACCINE - The present invention relates, in-general, to Human immunodeficiency virus (HIV), and in particular to a carbohydrate-based vaccine for HIV and to methods of making and using same. | 02-19-2015 |
Heather Deshazer, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20130130430 | SPATIALLY SELECTIVE LASER ANNEALING APPLICATIONS IN HIGH-EFFICIENCY SOLAR CELLS - Various laser processing schemes are disclosed for producing various types of hetero-junction emitter and homo-junction emitter solar cells. The methods include base and emitter contact opening, selective doping, metal ablation, annealing to improve passivation, and selective emitter doping via laser heating of aluminum. Also, laser processing schemes are disclosed that are suitable for selective amorphous silicon ablation and selective doping for hetero-junction solar cells. Laser ablation techniques are disclosed that leave the underlying silicon substantially undamaged. These laser processing techniques may be applied to semiconductor substrates, including crystalline silicon substrates, and further including crystalline silicon substrates which are manufactured either through wire saw wafering methods or via epitaxial deposition processes, or other cleavage techniques such as ion implantation and heating, that are either planar or textured/three-dimensional. These techniques are highly suited to thin crystalline semiconductor, including thin crystalline silicon films. | 05-23-2013 |
20130288425 | END POINT DETECTION FOR BACK CONTACT SOLAR CELL LASER VIA DRILLING - Methods and structures for fabricating photovoltaic back contact solar cells having multi-level metallization using laser via drilling end point detection are provided. | 10-31-2013 |
20140158193 | STRUCTURES AND METHODS OF FORMATION OF CONTIGUOUS AND NON-CONTIGUOUS BASE REGIONS FOR HIGH EFFICIENCY BACK-CONTACT SOLAR CELLS - Fabrication methods and structures relating to back contact solar cells having patterned emitter and non-nested base regions are provided. | 06-12-2014 |
Heather Eacker, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20100293697 | ARTICLE OF CLOTHING - An article of clothing includes a front portion and a rear portion, the rear portion being substantially enclosed across the torso. A location below the waist includes an opening that more readily allows the wearer to eliminate bodily waste. | 11-25-2010 |
Heather Eames, Lansdale, PA US
Patent application number | Description | Published |
---|---|---|
20100204733 | TRANSCONNECTOR - A transconnector for use in interconnecting a pair of longitudinal spinal rods in a spinal fixation procedure. The transconnector includes a bridge member and first and second spinal rod engaging members. The bridge member may include first and second members, wherein the first and second members are moveably associated with one another so that the distance between the first and second spinal rod engaging members can be adjusted. The first and second spinal rod engaging members include a rod receiving channel for receiving one of the spinal rods therein. The spinal rod engaging members may be articulating in, for example, the yaw and roll positions or non | 08-12-2010 |
Heather Fahlenkamp, Cleveland, OK US
Patent application number | Description | Published |
---|---|---|
20090011455 | DISEASE MODEL INCORPORATION INTO AN ARTIFICIAL IMMUNE SYSTEM (AIS) - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response. | 01-08-2009 |
20100105135 | POROUS MEMBRANE DEVICE THAT PROMOTES THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS - Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell® device. The resultant APCs, harvested from the lower Transwell® chamber, resemble other in vitro-generated DC populations in their expression of major histocompatibility (MHC) and costimulatory molecules, ability to phagocytose foreign antigens, and capacity to trigger antigen-specific T cell responses. | 04-29-2010 |
20100159443 | DISEASE MODEL INCORPORATION INTO AN ARTIFICIAL IMMUNE SYSTEM (AIS) - The present invention relates to methods for preparing an artificial immune system. The artificial immune system comprises a cell culture comprising a three-dimensional matrix comprising lymphoid tissue, a three-dimensional matrix comprising epithelial and/or endothelial cells, and diseased cells. The artificial immune system of the present invention can be used for in vitro testing of vaccines, adjuvants, immunotherapy candidates, cosmetics, drugs, biologics and other chemicals. | 06-24-2010 |
20100184148 | IN VITRO GERMINAL CENTERS - The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days. | 07-22-2010 |
20100279277 | METHODS OF EVALUATING A TEST AGENT IN A DISEASED CELL MODEL - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response. | 11-04-2010 |
20110171689 | ARTIFICIAL IMMUNE SYSTEM: METHODS FOR MAKING AND USE - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system. | 07-14-2011 |
20110250620 | METHODS OF EVALUATING AN IMMUNE RESPONSE TO AN ANTIGEN - The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days. | 10-13-2011 |
20110269176 | METHODS FOR ASSAYING RESPONSES TO VACCINES - The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days. | 11-03-2011 |
20120009561 | METHODS OF EVALUATING A TEST AGENT IN A DISEASED CELL MODEL - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response. | 01-12-2012 |
20130078656 | ARTIFICIAL IMMUNE SYSTEM: METHODS OF USE - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system. | 03-28-2013 |
20140273209 | ARTIFICIAL IMMUNE SYSTEM: METHODS OF USE - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system. | 09-18-2014 |
Heather Fahlenkamp, Broken Arrow, OK US
Patent application number | Description | Published |
---|---|---|
20100178676 | METHODS FOR ANTIBODY PRODUCTION - The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system. | 07-15-2010 |
Heather Fairhead, Histon GB
Patent application number | Description | Published |
---|---|---|
20140242032 | Modified Bacteriophage Including an Alpha/Beta Small Acid-Soluble Spore Protein (SASP) Gene - Provided is a modified bacteriophage capable of infecting a target bacterium, which bacteriophage includes an α/β small acid-soluble spore protein (SASP) gene encoding a SASP which is toxic to the target bacterium, wherein the SASP gene is under the control of a constitutive promoter which is foreign to the bacteriophage and the SASP gene. | 08-28-2014 |
Heather Fairhead, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100239536 | Modified Bacteriophage Including an Alpha/Beta Small Acid-Soluble Spore Protein (SASP) Gene - Provided is a modified bacteriophage capable of infecting a target bacterium, which bacteriophage includes an α/β small acid-soluble spore protein (SASP) gene encoding a SASP which is toxic to the target bacterium, wherein the SASP gene is under the control of a constitutive promoter which is foreign to the bacteriophage and the SASP gene. | 09-23-2010 |
Heather Ferrea, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20110091897 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES - Histochemical process compositions comprising at least one nanoparticle in an amount effective to reduce or substantially eliminate the average number of spots per slide that result from a sample staining protocol are disclosed. Various nanoparticles, or combinations thereof, including metals, metal alloys, metal oxides, ceramics, functionalized metals or metalloids, and other miscellaneous nanoparticles, such as carbon nanoparticles and diamond nanoparticles, can be used. The nanoparticle concentration typically is from about 2 parts per million to about 20 parts per million. One embodiment of a disclosed method concerns applying a histochemical process composition to a sample, followed by performing a staining protocol on the sample. Particular embodiments concern dispensing a nanosolution onto a sample using an automated system, heating the sample, and performing a sample staining process. | 04-21-2011 |
20140178929 | COMPOSITIONS COMPRISING NANOMATERIALS AND METHOD FOR USING SUCH COMPOSITIONS FOR HISTOCHEMICAL PROCESSES - Disclosed embodiments concern histochemical process compositions comprising at least one nanoparticle in an amount effective to reduce or substantially eliminate the average number of spots per slide that result from a sample staining protocol. The nanoparticle can be any of various nanoparticles, or combinations thereof, including metals, metal alloys, metal oxides, ceramics, functionalized metals or metalloids, and other miscellaneous nanoparticles, such as carbon nanoparticles and diamond nanoparticles. Typically, the nanoparticle concentration is from greater than zero to at least about 25 parts per million, more typically from about 2 parts per million to about 20 parts per million. Embodiments of a method for using process nanosolutions also are disclosed. One embodiment concerns applying a histochemical process composition to a sample, followed by performing a staining protocol on the sample. Particular embodiments concern automated histochemical processes comprising dispensing a nanosolution onto a sample using an automated system, heating the sample, and performing a sample staining process on the sample. | 06-26-2014 |
Heather Fielder Horton, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20110159265 | High Strength and High Elongation Wipes - The present invention provides high strength nonwoven wipe materials and the process of making the materials. The high strength nonwoven wipe materials contain cellulosic fibers, synthetic fibers, or mixtures thereof, with bicomponent fibers and optionally, a binder. The present invention provides a high strength, high elongation, reduced stiffness nonwoven wipe material with superior tensile strength. | 06-30-2011 |
Heather Gornik, Cleveland, OH US
Patent application number | Description | Published |
---|---|---|
20110040572 | METHOD AND SYSTEM FOR MONITORING AND MANAGING PATIENT CARE - A patient management system includes a patient unit that obtains results data from a patient device and provides for two-way communication between the patient unit and a remote database. The patient unit can communicate with the remote database to obtain encounter instruction data for a given encounter as well as to send response data for the given encounter. A back office system can also access the database to retrieve the patient data for one or more patient users. The back office system can further add or modify encounter instruction data for use during a next encounter at the patient unit. The back office system can also set a dosage for the patient that can be stored in the remote database and retrieved by the patient unit as part of the given encounter. The back office system may also employ a rules engine that can be programmed according to an established protocol and can automatically generate encounter instructions and dosage information for one or more patient. | 02-17-2011 |
Heather Green, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20100299781 | RESPONSES TO SINGLET OXYGEN - The physiological response of an organism to singlet oxygen is altered by modulating the interaction between an anti-sigma factor, ChrR, and a sigma factor, σ | 11-25-2010 |
Heather Greenstone, Silver Spring, MD US
Patent application number | Description | Published |
---|---|---|
20090203113 | CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES - The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines. | 08-13-2009 |
20100172936 | CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES - The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines. | 07-08-2010 |
Heather Grudt, Minneapolis, MN US
Patent application number | Description | Published |
---|---|---|
20120150634 | ELECTRONIC PERIODICAL ADVERTISEMENT - An electronic periodical advertisement including a number of time dependent offers is generated, e.g., using a computing device. The offers are organized into a number of modules. A default set of the modules is presented to a user. The default set of modules is edited to generate a user-defined set of modules. A user-defined electronic periodical advertisement including the user-defined set of modules is presented to the user. | 06-14-2012 |
Heather Hamilton, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20140277226 | EXTERNALLY-SECURED MEDICAL DEVICE - Certain embodiments of the present disclosure provide an externally-secured medical device (ESMD) configured to be securely affixed to skin of a patient. The ESMD may include at least one pad configured to be directly secured to the skin of the patient. The pad(s) may include at least one electrode configured to direct therapeutic energy into the skin of the patient toward an internal organ. An adhesion component is provided on a patient-engaging surface of the at least one pad configured to securely affix the at least one pad in a persistent and enduring manner to the skin of the patient. The at least one pad is directly secured to the skin of the patient through the adhesion component. | 09-18-2014 |
Heather Hane-Karr, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20100087763 | Hand-held cradle for ball massage - A massage implement is provided that incorporates the use of commonly available golf balls, or other objects of similar dimensions and properties. The massage implement comprises a rigid or semi-rigid housing to hold a golf ball, a cavity to allow such golf ball to move freely within the implement, a comfortable and ergonomically balanced shape, finger impressions for greater control and grip, and other built-in utilities essential to a proper massage and other affiliated uses. | 04-08-2010 |
Heather Hettrick, Atlantic Highlands, NJ US
Patent application number | Description | Published |
---|---|---|
20120270196 | SYSTEMS AND METHODS FOR VIRTUAL WOUND MODULES - Wound care systems and methods are disclosed that provide users with interactive instruction for chronic wound care. The system presents a visual depiction of a patient with a chronic wound and a visual depiction of wound characteristics, cross-section of the wound and interactive wound care tools. Further, the system presents a visual map having on-screen graphics representing at least one of tissue consistency, tissue texture, tissue temperature, tissue moisture and tissue tenderness for a virtual chronic wound. At least some of the on-screen graphics represent visual cues for the wound care such that a user is provided with a visual indication of the response of the virtual wound to the care the user virtually provides. Administrators can select care modules to build custom training tutorials. In addition, the system tracks the user interaction with the virtual training to provide feedback to the administrator or the user. | 10-25-2012 |
Heather Himburg, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20110293574 | Hematopoietic stem cell growth factor - The present invention relates, in general, to stem cells and, in particular, to a hematopoietic stem cell (HSC) growth factor and to methods of using same. | 12-01-2011 |
Heather Hoops, Golden, CO US
Patent application number | Description | Published |
---|---|---|
20090192389 | INNOVATIVE COMPONENTS FOR AN ULTRASONIC ARC SCANNING APPARATUS - Embodiments of the present invention are directed to various aspects of imaging systems, including permeable and impermeable barriers separating liquid compartments, one of which contains the object to be imaged and the other an ultrasonic transducer, a fluidic bearing between a transducer carriage and guide supporting the carriage, a linear motor for the carriage, and a location sensing device for the carriage. | 07-30-2009 |
20140249422 | INNOVATIVE COMPONENTS FOR AN ULTRASONIC ARC SCANNING APPARATUS - Embodiments of the present invention are directed to various aspects of imaging systems, including permeable and impermeable barriers separating liquid compartments, one of which contains the object to be imaged and the other an ultrasonic transducer, a fluidic bearing between a transducer carriage and guide supporting the carriage, a linear motor for the carriage, and a location sensing device for the carriage. | 09-04-2014 |
Heather Huot Creasy, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20120070457 | Polypeptides from neisseria meningitidis - Polypeptides comprising | 03-22-2012 |
Heather Jordan, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20140248705 | NUCLEIC ACID LADDERS - The present invention provides nucleic acid compositions or ladders which may be used as standards for estimating the size (in base pairs) and or mass of nucleic acid molecules of unknown size and/or mass. The invention also relates to methods for producing such compositions or ladders, ladders or compositions produced by such methods, and to methods for estimating the size and/or mass of nucleic acid molecules by comparison to these nucleic acid sizing ladders. | 09-04-2014 |
Heather Keltz, Maplewood, NJ US
Patent application number | Description | Published |
---|---|---|
20120323705 | Method For Online Session Advertising - The invention provides a method of providing and selling online advertising in which a single advertiser is guaranteed major advertising locations on each qualifying page viewed by a web site visitor during the viewer's entire web session. Advertisements from a single advertiser follow web site visitors through the web pages they select for viewing, allowing a consistent message to be displayed to a particular user over a period of time. Advantages include the ability to engage in linear storytelling and to obtain reach, duration, and impact of the advertising message on a par with or exceeding that obtainable from conventional advertising media such as television and print. | 12-20-2012 |
Heather Kobzan, Pickering CA
Patent application number | Description | Published |
---|---|---|
20110131721 | BATHTUB BACK SUPPORT SYSTEMS - A back rest device for a bathtub comprising a rest member having a front surface and a back surface, at least one suction cup, a cover with pockets, and at least one insertable pillow. The rest member is placed against a bathtub back and on a cushioned bathmat that suctions to the floor of the bathtub. The suction cups are attached to the back surface of the rest member to facilitate the attachment of the rest member to the bathtub back. The cover with pockets is attached to the front surface of the rest member and the insertable pillow is placed inside the pockets to create additional comfort. | 06-09-2011 |
Heather Konet, Canton, MI US
Patent application number | Description | Published |
---|---|---|
20090318069 | CONTACT-FREE VEHICLE AIR VENT - A contact-free air vent flow direction control device includes an air vent, a positioning mechanism, a touch-less motion sensor and a control unit. The air vent has at least one flow control blade configured to move between a plurality of predetermined orientations each corresponding to a direction of air flow from the air vent. The positioning mechanism is operably coupled to the flow control blade. The touch-less motion sensor is configured to detect relative movement of objects proximate the touch-less motion sensor. The control unit is operably connected to the touch-less motion sensor and the positioning mechanism to control operation of the positioning mechanism in order to position the flow control blade in a selected one of the predetermined orientations in response to a corresponding one of a plurality of predetermined movements detected by the touch-less motion sensor. | 12-24-2009 |
20120068836 | SYSTEM AND METHOD FOR PRODUCING AN AUDIBLE ALERT FOR A VEHICLE - A method for controlling a vehicle to emanate an audible alert. The method includes determining when the vehicle is operating, and controlling a speaker system in the vehicle to emanate the audible alert outside of the vehicle for a period of time when the vehicle is operating. The audible alert has a sound profile that includes a simultaneous emanation of a first audible frequency component at a first sound pressure level and a second audible frequency component at a second sound pressure level, with the first and second sound pressure levels being greater than a sound pressure level of the sound profile at all other frequencies. The method further includes modulating the first sound pressure level of the first audible frequency component. | 03-22-2012 |
20120221189 | VEHICLE USER DISTANCE MEASURING SYSTEM - A distance measuring system comprises a vehicle and an electronic key. The vehicle includes a user interface system. The portable electronic key includes a distance data gathering component configured to determine a distance travelled by the electronic key and create distance data based on the distance travelled, and a communication component configured to communicate the distance data to the user interface system which is configured to output distance information based on the distance data. | 08-30-2012 |
20130002414 | VEHICLE METER CLUSTER - A vehicle meter cluster basically includes a meter cluster housing, an instrument display, a lens and a light source. The lens is disposed in front of the instrument display and includes a reflective area. The light source is mounted on the meter cluster housing or proximate to the meter cluster housing. The light source is configured to selectively emit light toward the reflective area of the lens to selectively provide warning information on the reflective area. | 01-03-2013 |
20130214920 | METHOD OF EMANATING A SOUND FROM A VEHICLE - A method of emanating a sound from a vehicle includes detecting a transmission state and a brake state of the vehicle and determining whether a vehicle movement state indicates intent to move the vehicle from a stationary state based on the transmission state and the brake state. The method further includes emanating the sound when the vehicle movement state indicates intent to move the vehicle, and refraining from emanating the sound when the vehicle is in the stationary state and the vehicle movement state fails to indicate intent to move the vehicle. | 08-22-2013 |
Heather Koshinsky, El Cerrito, CA US
Patent application number | Description | Published |
---|---|---|
20080220436 | METHODS AND COMPOSITIONS FOR RAPID LIGHT-ACTIVATED ISOLATION AND DETECTION OF ANALYTES - The present invention relates to novel methods for isolating a target molecule from a sample suspected of containing the target molecule. The methods of the present invention utilize solid substrates as a means for capturing, separating, and releasing target molecules, such as chemical or biological compounds. The present invention is specifically directed to novel approaches for capturing, separating and releasing such target molecules. | 09-11-2008 |
20100049445 | METHOD AND APPARATUS FOR SEQUENCING DATA SAMPLES - A method for identifying non-host nucleic acid sequence using sequence data. The method of identifying non-host nucleic acid can include sequencing a sample into sequences and associating the sequences with a host genome and then exclude any sequences that are associated with the host genome. The method can then associate the sequences with any known genomes and exclude any sequences that are associated with any known genome. The remaining sequences can be used as seed sequences to assemble a non-host nucleic acid. | 02-25-2010 |
20100209909 | ASSAYS BASED ON DETECTION OF PHOTOBLEACHING REACTION PRODUCTS FROM DYE CATALYTIC COMPLEX - The present invention relates to the methods for assaying an analyte comprising a nucleic acid analog binding substrate in a sample, comprising reacting a catalytic complex comprising a nucleic acid analog, a nucleic acid analog specific binding substrate and a light reactive dye with a light stimulus, and detecting the presence or absence or amount of a reaction product of the catalytic complex and light stimulus. The present invention also relates to a method of assaying a nucleic acid analyte in a sample using an analyte-specific reporter complex. The present invention also relates to a method of assaying an analyte in a sample using a reporter molecule. | 08-19-2010 |
20110008905 | SYSTEM FOR DETECTING POLYNUCLEOTIDES - The present invention relates to methods for detecting the presence or amount of a target polynucleotide. A polynucleotide, target nucleic acid analog, and dye are combined to form a mixture. The optical property of the dye is observed after the mixture is exposed to a stimulating means. Optionally, after the stimulating means is employed, the mixture is compared to a reference value characteristic of the rate of change in the optical property of the dye in a similar mixture containing a known amount of a target polynucleotide/nucleic acid analog hybrid to determine a relative rate of change in the optical property. The change in a property of the mixture after exposure thereof to a stimulating means or the relative rate of change in the optical property of dye in the mixture is correlated with the presence or amount of the specified target polynucleotide in the sample. | 01-13-2011 |
Heather Lane-Brown, Honeoye Falls, NY US
Patent application number | Description | Published |
---|---|---|
20090176247 | Determination of sFlt-1:Angiogenic Factor Complex - Methods for determining the presence or amount of a complex comprising a first and second molecular entity are provided, preferably an sFlt-1:PlGF complex. A determination of the presence or amount of the complex can be used in methods for predicting, detecting, monitoring a disease, or guiding therapy in respect to a disease such as vascular, vascular-related disease, cardiac, cardiac-related disease, cancer, cancer-related disease, preeclampsia, and preeclampsia-related disease. Determining sFlt- | 07-09-2009 |
20140377778 | Determination of sFlt-1:Angiogenic Factor Complex - Methods for determining the presence or amount of a complex comprising a first and second molecular entity are provided, preferably an sFlt-1:PlGF complex. A determination of the presence or amount of the complex can be used in methods for predicting, detecting, monitoring a disease, or guiding therapy in respect to a disease such as vascular, vascular-related disease, cardiac, cardiac-related disease, cancer, cancer-related disease, preeclampsia, and preeclampsia-related disease. Determining sFlt-1:angiogenic factor complex is particularly useful for predicting and detecting preeclampsia in early stages of gestation and in stages of the disease where clinical evaluation may be uninformative. | 12-25-2014 |
Heather Lindenman, Otterbein, IN US
Patent application number | Description | Published |
---|---|---|
20110106164 | APPARATUS FOR IMPLEMENTING A SPINAL FIXATION SYSTEM WITH SUPPLEMENTAL FIXATION - An apparatus for implementing a spinal fixation system with supplemental fixation includes a spinal fixation rod assembly and at least one supplemental fixation device. The spinal fixation rod assembly is adapted to provide primary fixation at a plurality of first fixation points by being secured to a plurality of first vertebral components except not into one of the first vertebral components of the plurality that is in a weakened structural condition and located between other of the first vertebral components of the plurality. The supplemental fixation device is adapted to provide supplemental fixation for the assembly at a second fixation point by being secured to a second vertebral component located adjacent to and offset from the one first vertebral component in the weakened structural condition and also to interconnect with the assembly to provide anchorage and thus additional fixation supplemental to the primary fixation. | 05-05-2011 |
Heather Lindenman, Germantown, TN US
Patent application number | Description | Published |
---|---|---|
20110301650 | ADJSUTABLE BONE ANCHOR ASEMBLY - A medical implant device has in one embodiment a receiver member for receiving an elongated member, a crown member, an anchor member and a retaining member. An embodiment of the receiver member has an axial opening, a transverse channel, a chamber including at least one substantially flat wall, and a groove. An embodiment of the crown member has at least one substantially flat side. An embodiment of the anchor member has a head with at least one substantially flat surface that may be parallel to the anchor member's longitudinal axis, and an anchoring portion. An embodiment of the retaining member is a substantially flat clip. The crown member and anchor member are inserted into the chamber, and the retaining member is inserted into the groove beneath them. The anchor member may be pivoted substantially in one plane with respect to the receiver member until locked. | 12-08-2011 |
Heather Lossing, Hamilton CA
Patent application number | Description | Published |
---|---|---|
20100126929 | MEMBRANE SUPPORTED BIOFILM APPARATUS AND PROCESS - A membrane supported biofilm apparatus has a plurality of hollow fiber gas permeable membranes in a tank containing water to be treated. The membranes have an outside diameter of about 200 microns or less and occupy between 0.5% and 4% of the tank volume. A biofilm supported on the membranes occupies between about 40% and 80% of the volume of water to be treated in a reactor. The membranes may be oriented generally vertically and a spreader may be located near the bottom of the apparatus to disperse the membranes. Wastewater treatment processes are described. A process to dentrify water or treat oxidized contaminants comprises introducing hydrogen into an inner volume of the membranes to grow autotrophic organisms in the biofilm near the membrane and heterotrophic organism near the water. Another process is operated at a biomass concentration of at least 10 g/L and up to about 40 g/L to maintain a biofilm having a surface area of over 1000 square metres per cubic metre of tank volume. A hybrid process has suspended biomass and a membrane supported biofilm. | 05-27-2010 |
20130161254 | MEMBRANE SUPPORTED BIOFILM APPARATUS AND PROCESS - A membrane supported biofilm apparatus has a plurality of hollow fiber gas permeable membranes in a tank containing water to be treated. A biofilm supported on the membranes occupies between about 40% and 80% of the volume of water to be treated in a reactor. Wastewater treatment processes are described. A process to denitrify water or treat oxidized contaminants comprises introducing hydrogen into an inner volume of the membranes to grow autotrophic organisms in the biofilm near the membrane and heterotrophic organism near the water. Another process is operated as a biomass concentration of at least 10 g/L and up to about 40 g/L to maintain a biofilm having a surface area of over 1000 square metres per cubic metre of tank volume. A hybrid process has suspended biomass and a membrane supported biofilm. | 06-27-2013 |
20140008280 | MEMBRANE SUPPORTED BIOFILM APPARATUS AND PROCESS - A membrane supported biofilm apparatus has a plurality of hollow fiber gas permeable membranes in a tank containing water to be treated. A biofilm supported on the membranes occupies between about 40% and 80% of the volume of water to be treated in a reactor. Wastewater treatment processes are described. A process to denitrify water or treat oxidized contaminants comprises introducing hydrogen into an inner volume of the membranes to grow autotrophic organisms in the biofilm near the membrane and heterotrophic organism near the water. Another process is operated as a biomass concentration of at least 10 g/L and up to about 40 g/L to maintain a biofilm having a surface area of over 1000 square metres per cubic metre of tank volume. A hybrid process has suspended biomass and a membrane supported biofilm. | 01-09-2014 |
Heather Macuszonok, Orlando, FL US
Patent application number | Description | Published |
---|---|---|
20120198914 | Pressure Activated Sampling System - Screening an item for prohibited material may include multiple pressurization and rapid depressurization cycles. Screening an item for prohibiting material may include a pressurization chamber including one or more items to be screened for prohibited material and one or more filler objects. | 08-09-2012 |
Heather Maecker, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20080286271 | Methods and Compositions for Modulating Tweak and Fn14 Activity - Agonists and antagonists which modulate the activity of TWEAK and TWEAK receptor are provided. The methods, compositions and kits of the invention may be employed in the treatment of disorders such as cancer and immune-related diseases. | 11-20-2008 |
20100203056 | ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION - The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. | 08-12-2010 |
20120269808 | METHODS AND COMPOSITIONS FOR MODULATING TWEAK AND FN14 ACTIVITY - Agonists and antagonists which modulate the activity of TWEAK and TWEAK receptor are provided. The methods, compositions and kits of the invention may be employed in the treatment of disorders such as cancer and immune-related diseases. | 10-25-2012 |
20130045200 | METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO TREAT INFECTION RESULTING FROM T-CELL DYSFUNCTION - The present application relates to methods of using anti-PD-L1 antibodies to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. | 02-21-2013 |
20130045201 | METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY - The present application relates to methods of using anti-PD-L1 antibodies to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. | 02-21-2013 |
20130045202 | ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE - The present application relates to anti-PD-L1 antibodies, which have therapeutic use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. | 02-21-2013 |
20140065135 | METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY - The present application relates to methods of using anti-PD-L1 antibodies to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity. | 03-06-2014 |
20140341902 | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS - The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer. | 11-20-2014 |
Heather Mallinger, Washington, MI US
Patent application number | Description | Published |
---|---|---|
20120153603 | AIRBAG VENT ASSEMBLY - An airbag cushion of flexible sheet material has a vent opening therein with a vent cover of flexible sheet material stitched to an interior surface of the airbag cushion aligned with the vent opening in the airbag cushion to form a pocket. The vent cover has a vent opening therein that allows airbag inflation gas to escape from the airbag cushion via the vent opening in the airbag cushion. A vent flap of flexible sheet material is disposed at least partially within the pocket and inboard of the vent openings in the airbag cushion and vent cover. The vent flap is fixed to at least one tether that extends outboard from the vent flap through an opening in the vent cover to a tether end that is permanently attached to the airbag cushion outboard of the vent cover. A tether extends inboard from vent flap to a tether end that is fixed in a releasable manner to a tether end securing device fixed to a module housing. The tether end securing device reacts to a signal to release the end of the tether when a sensor senses a predetermined parameter during deployment of the airbag. The vent flap is pulled in an outboard direction by a tether to become interposed between the vent openings in the airbag cushion and the vent cover and prevent the escape of inflation gas through the vent openings in the airbag cushion and the vent cover. | 06-21-2012 |
20120205900 | AIRBAG CUSHION - An airbag cushion ( | 08-16-2012 |
20130221644 | AIRBAG WITH MULTI-STATE VENT - An air bag having a tri-state vent, in an initial state the vent is configured to be closed, the vent in a medial state configured to be at least partially open or fully open as the air bag is starting to inflate permitting some inflator gas to exit through the vent and the vent in a final state configured to be at least partially closed or fully closed as the air bag continues to inflate. | 08-29-2013 |
Heather Mastny, Dublin, OH US
Patent application number | Description | Published |
---|---|---|
20140209701 | Passive Diffuser Having a Non-Planar Wick - A device for passively diffusing a liquid to the air of a surrounding area. A reservoir holds the liquid, the reservoir having a top end with an aperture therethrough. A non-planar wick extends through the aperture such that a lower end of the wick remains in contact with the liquid in the reservoir and an upper end of the wick is exposed to the surrounding area. The wick is formed of a fibrous, porous sheet of material having a top edge and a bottom edge of substantially the same width. The sheet of material is gradually gathered along a length of the sheet of material such that the upper end of the wick is less gathered than the lower end of the wick and the wick is self-supported in an upright position within the aperture. | 07-31-2014 |
Heather Mccaig, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20130043143 | DEVICE FOR DETECTING GASES AND/OR VOLATILE ORGANIC COMPOUNDS (VOC) - The present invention concerns a device for detecting gases or volatile organic compounds (VOC) comprising an electrically conducting or semiconducting zone f unctionalized with an organic film resulting from the polymerization of aromatic diazonium salt derived monomer. | 02-21-2013 |
20130098141 | LOCALIZED DEPOSITION OF POLYMER FILM ON NANOCANTILEVER CHEMICAL VAPOR SENSORS BY SURFACE-INITIATED ATOM TRANSFER RADICAL POLYMERIZATION - Cantilever chemical vapor sensors that can be tailored to respond preferentially in frequency by controlling the location of deposition of an adsorbing layer. Cantilever chemical vapor sensor having a base, one or more legs and a tip are fabricated using a gold layer to promote deposition of a sorbing layer of a polymeric material in a desired location, and using a chromium layer to inhibit deposition of the sorbing layer in other locations. Sorbing layers having different glass temperatures Tg and their effects are described. The methods of making such cantilever chemical vapor sensors are described. | 04-25-2013 |
Heather Mccallum-Bayliss, Mclean, VA US
Patent application number | Description | Published |
---|---|---|
20080312909 | SYSTEM FOR ADAPTIVE MULTI-CULTURAL SEARCHING AND MATCHING OF PERSONAL NAMES - An automated name searching system incorporates an automatic name classifier and a multi-path architecture in which different algorithms are applied based on cultural identity of the query name. The name classifier operates with a preemptive list, analysis of morphological elements, length, and linguistic rules. A name regularizer produces a character based computational representation of the name. A pronunciation equivalent representation such as an IPA language representation, and language specific rules to generate name searching keys, are used in a first pass to eliminate database entries which are obviously not matches for the query name. The methods can also be implemented as a callable set of library routines including an intelligent preprocessor and a name evaluator that produces a score comparing a query name and database name, based on a variety of user-adjustable parameters. The user-controlled parameters permit tuning of the search methodologies for specific custom applications. | 12-18-2008 |
Heather Mccrabb, Kettering, OH US
Patent application number | Description | Published |
---|---|---|
20110017608 | ELECTROCHEMICAL ETCHING AND POLISHING OF CONDUCTIVE SUBSTRATES - A method for electrochemically etching a metal layer through an etch-resist layer pattern using a non-active electrolyte solution is described. The method is particularly useful in fabrication of advanced fuel delivery systems for land-based power generation turbines and aerospace turbine engines; of components for advanced thermal management in aerospace electronic devices and in cooling channels; of stents used in medicine; and of microchannels for sensors, chemical reactors, and dialysis and the like. In one embodiment of the invention the metal layer is copper and the non-active electrolyte solution is a mixture of sodium nitrate and sodium chloride and a pulse electric current is employed to accomplish the electrochemical etching. | 01-27-2011 |
20120091000 | ELECTROLYTIC SYSTEM AND METHOD FOR FILTERING AN AQUEOUS PARTICULATE SUSPENSION - An electrolytic filtration method and apparatus for the concentration and collection of suspended particulates from aqueous solutions is disclosed. The electrolytic cell contains at least an anode and a cathode, and in one embodiment contains a plurality of anodes and cathodes. The electrolytic cell also contains a filter, and in one embodiment the filter is a moving belt filter. While not bound by theory, the electrolytic filtration method and apparatus is based on the electrophoretic movement of algae particles suspended in an aqueous solution away from the filter under the influence of an electric field. In one embodiment the electric field is a pulsed waveform with unidirectional voltage or current pulses. In another embodiment, the electric field is a pulsed waveform with bidirectional voltage or current pulses. | 04-19-2012 |
Heather Mcfavilen, Tempe, AZ US
Patent application number | Description | Published |
---|---|---|
20140264371 | SEMICONDUCTOR STRUCTURES HAVING ACTIVE REGIONS COMPRISING INGAN, METHODS OF FORMING SUCH SEMICONDUCTOR STRUCTURES, AND LIGHT EMITTING DEVICES FORMED FROM SUCH SEMICONDUCTOR STRUCTURES - Semiconductor structures include an active region between a plurality of layers of InGaN. The active region may be at least substantially comprised by InGaN. The plurality of layers of InGaN include at least one well layer comprising In | 09-18-2014 |
20140264408 | SEMICONDUCTOR STRUCTURES HAVING ACTIVE REGIONS COMPRISING INGAN, METHODS OF FORMING SUCH SEMICONDUCTOR STRUCTURES, AND LIGHT EMITTING DEVICES FORMED FROM SUCH SEMICONDUCTOR STRUCTURES - Semiconductor structures include an active region between a plurality of layers of InGaN. The active region may be at least substantially comprised by InGaN. The plurality of layers of InGaN include at least one well layer comprising In | 09-18-2014 |
Heather Mcfelea, Tempe, AZ US
Patent application number | Description | Published |
---|---|---|
20120085400 | METHODS OF FABRICATING SEMICONDUCTOR STRUCTURES AND DEVICES USING QUANTUM DOT STRUCTURES AND RELATED STRUCTURES - Methods of fabricating photovoltaic devices include forming a plurality of subcells in a vertically stacked arrangement on the semiconductor material, each of the subcells being formed at a different temperature than an adjacent subcell such that the adjacent subcells have differing effective band-gaps. The methods of fabricating also include inverting the structure, attaching another substrate to the second semiconductor material, and removing the substrate. For example, each of the subcells may comprise a III-nitride material, and each subsequent subcell may include an indium content different than the adjacent subcell. Novel structures may be formed using such methods. | 04-12-2012 |
Heather Messal, Marina Del Rey, CA US
Patent application number | Description | Published |
---|---|---|
20110226828 | PERSONAL ITEM CARRIER - An exercise harness for wearing by a user, including a front piece; a back piece; two shoulder straps a first shoulder strap configured to attach between the front piece and the back piece over the user's left shoulder and a second strap configured to attach between the front piece and the back piece over the user's right shoulder; a chest strap coupled from below to the front piece and the back piece and configured to surround the body of the user and prevent movement of the front piece and back piece during activity of the user; and wherein the front piece and the back piece both include pockets and wherein the length of the straps are designed to position the front piece and the back piece above the waist of the user at about the center of gravity of the user. | 09-22-2011 |
Heather Newman, Sebastopol, CA US
Patent application number | Description | Published |
---|---|---|
20140344670 | METHOD AND SYSTEM FOR ON-DEMAND DELIVERY OF PREDEFINED IN-CONTEXT WEB CONTENT - A method of supplying supplemental content to a browser displaying a web page includes: receiving a request to register supplemental content, the request including a web page identifier; determining whether the web page is registered to receive supplemental content; supplying instructions to the web browser if the web page is registered to receive supplemental content; receiving a request to supply supplemental content, the request comprising a node identifier; and supplying supplemental content in accordance with the node identifier. | 11-20-2014 |
Heather Patisaul, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20110194679 | Communication Ranking and Organization - Methods and apparatuses are disclosed herein for organizing communication information. Data received associated with a communication is recorded at the communication device. An identifier is associated with the communication. The identifier indicates a unique identity. A call score is calculated for the identifier at the communication device based on the communication. The particular identifier is ranked in a list in accordance with the calculated call score. | 08-11-2011 |
Heather Pieraldi, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20130219748 | Multi-Piece Upper for Athletic Footwear - In one embodiment, an article of footwear includes a sole and an upper attached to the sole. The upper and sole and configured to envelop at least a portion of human foot. The upper further includes a forefoot member attached to a forefoot portion of the sole and a heel member attached to a heel portion of the sole. The forefoot member and heel member are detached from each other at a location above the sole to enable individual adjustment of the forefoot member and the heel member. | 08-29-2013 |
20130219752 | Energy Return Member for Footwear - In at least one embodiment, an article of footwear includes a sole defining a lateral side and a medial side, an upper attached to the sole, and a resilient member positioned within the sole. The resilient member includes a plurality of arms including a medial arm extending along the medial side of the sole and a lateral arm extending along the lateral side of the sole, wherein an end of the medial arm is connected to an end of the lateral arm. | 08-29-2013 |
Heather Prattas, Surfside, FL US
Patent application number | Description | Published |
---|---|---|
20090212083 | DEVICE HOLDER OF A TRANSPORT APPARATUS - A device holder for a transport apparatus having a user storage compartment which includes a main body detachably coupled to the transport apparatus and a device storage compartment disposed on the main body to store a device therein, wherein the main body is coupled to the transport apparatus to provide a line of sight to a user disposed in the user storage compartment. | 08-27-2009 |
Heather Rasmussen, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20140212494 | Methods of Improving Digestive Health - A method of treating constipation is disclosed. The method includes administering starch-entrapped microbeads. | 07-31-2014 |
Heather Raymon, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090270418 | PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH - Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure: | 10-29-2009 |
20120129807 | METHODS OF TREATMENT, IMPROVEMENT AND PREVENTION USING HALOARYL SUBSTITUTED AMINOPURINES - Provided herein are Aminopurine Compounds having the following structure: | 05-24-2012 |
20130102613 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS - Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a solid tumor, non-Hodgkin lymphoma or multiple myeloma. | 04-25-2013 |
20130245026 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS - Provided herein are methods for treating or preventing head and neck squamous cell carcinoma, comprising administering an effective amount of a TOR kinase inhibitor to a patient having head and neck squamous cell carcinoma. | 09-19-2013 |
20130245027 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS - Provided herein are methods for treating or preventing triple negative breast cancer or hormone receptor positive breast cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having triple negative breast cancer or hormone receptor positive breast cancer. | 09-19-2013 |
20130245028 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS - Provided herein are methods for treating or preventing ETS overexpressing castration-resistant prostate cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having ETS overexpressing castration-resistant prostate cancer. | 09-19-2013 |
20140113904 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS - Provided herein are methods for treating or preventing prostate cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having prostate cancer. | 04-24-2014 |
20140314673 | TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES - Provided herein are methods for treating or preventing head and neck squamous cell carcinoma characterized by deletion of chromosome 11q22 or loss of ataxia telangiectasia mutated expression, comprising administering an effective amount of a dihydropyrazino-pyrazine to a patient having head and neck squamous cell carcinoma characterized by deletion of chromosome 11q22 or loss of ataxia telangiectasia mutated expression. | 10-23-2014 |
20140314674 | TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES - Provided herein are methods for treating or preventing glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound to a patient having glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status. | 10-23-2014 |
20140315848 | METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY - Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of a cytidine analog to a patient having a cancer. | 10-23-2014 |
20140315900 | METHODS FOR TREATING CANCER USING DIHYDROPYRAZINO-PYRAZINE COMPOUND COMBINATION THERAPY - Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound and an effective amount of an androgen receptor antagonist to a patient having a cancer. | 10-23-2014 |
20140315907 | TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES - Provided herein are methods for treating or preventing chronic lymphocytic leukemia, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound to a patient having chronic lymphocytic leukemia. | 10-23-2014 |
Heather Rechtin, St. Louis, MO US
Patent application number | Description | Published |
---|---|---|
20130247319 | Oral Utensil - According to certain embodiments of the present disclosure, an oral utensil includes at least an elongated body having a longitudinal axis extending therethrough, a distal end portion configured for executing an oral care task, and a proximal end portion having a protrusion extending in a substantially orthogonal relation from the longitudinal axis and positioned upon the proximal end portion such that it abuts the palm of a user. | 09-26-2013 |
20140304929 | ORAL UTENSIL - Oral utensils having at least one central protrusion are disclosed. The oral utensils are configured for modification of a gag reflex in a user of the oral utensil. The oral utensils may comprise a handle portion comprising at least one central protrusion and a first head portion comprising a dental tool, wherein the handle portion may be removably connected to the head portion. | 10-16-2014 |
Heather Rohllf, Clifton, NJ US
Patent application number | Description | Published |
---|---|---|
20110305547 | Retractable Tool for Collecting Craft Objects - A retractable herding apparatus comprises a housing, a tap drum, a retractable tape, and a biasing member. The housing has an interior cavity, a sidewall and an opening defined in the sidewall to provide access into the cavity. The tape drum is rotatably disposed in the housing. The retractable tape has a first end and a second end. The first end of the retractable tape is attached to the tape drum. The second end of the retractable tape is attached to the housing proximate the opening in the sidewall. The retractable tape is movable between a fully retracted position and a fully protracted position. The biasing member couples to the tape drum. The biasing member is provided to bias the retractable tape toward the retracted position. | 12-15-2011 |
20130017043 | Retractable Tool for Collecting Craft Objects - A retractable herding apparatus comprises a housing, a tap drum, a retractable tape, and a biasing member. The housing has an interior cavity, a sidewall and an opening defined in the sidewall to provide access into the cavity. The tape drum is rotatably disposed in the housing. The retractable tape has a first end and a second end. The first end of the retractable tape is attached to the tape drum. The second end of the retractable tape is attached to the housing proximate the opening in the sidewall. The retractable tape is movable between a fully retracted position and a fully protracted position. The biasing member couples to the tape drum. The biasing member is provided to bias the retractable tape toward the retracted position. | 01-17-2013 |
Heather Savage-Erickson, Memphis, TN US
Patent application number | Description | Published |
---|---|---|
20100262244 | Metal Coated Implant - A metal coated implant and a method for using the implant for expanding an intervertebral disc space is provided. The implant comprises a polymer substrate and a metallic coating layer wherein the metallic coating layer is attached to the polymer substrate. There metal coated implant further comprising a biocompatible radiolucent polyetheretherketone (PEEK) material, and a metallic coating layer that is a titanium (Ti) or gold (Au) material. The metal coated implant's radiolucent and radiopaque properties enhance a surgeon's ability to distinctly visualize the metal coated implant to thereby better control and maneuver the delivery, insertion, trajectory, position and orientation of the metal coated implant through the patient anatomical environment and into the vertebral disc space. | 10-14-2010 |
Heather Schenck Mortell, Neenah, WI US
Heather Schmidt, Santa Rosa, CA US
Patent application number | Description | Published |
---|---|---|
20120083153 | MULTIFUNCTIONAL ACCESSORIES FOR MOBILE DEVICES - A multifunctional accessory for a mobile device, in one example embodiment, comprises an anterior assembly, which includes a plurality of sides and an anterior aperture for viewing and providing access to the mobile device, with the plurality of anterior sides and the anterior aperture forming an anterior recess. The accessory further comprises a posterior assembly including a plurality of posterior sides and a posterior panel, with the plurality of posterior sides and the posterior panel forming a posterior recess, wherein the anterior and posterior recesses accommodate the mobile device. The accessory further comprises a hinge assembly to pivotally couple the anterior assembly and the posterior assembly at one or more of the plurality of anterior sides and the plurality of posterior sides, with the hinge assembly allowing the anterior assembly and the posterior assembly to pivot about each other along one or more edge axes securing the mobile device at an adjustable viewing angle. | 04-05-2012 |
Heather Skor, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140234854 | METHOD FOR EVALUATION OF PRESENCE OF OR RISK OF COLON TUMORS - The disclosed methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management. The methodology provided herein is intended to detect technical variations and to allow for data normalization and enhance signal detection and build predictive proteins profiles of disease status and response. | 08-21-2014 |
Heather Tomeo, Avon, IN US
Patent application number | Description | Published |
---|---|---|
20120282634 | BLOOD SEPARATION SYSTEM AND METHOD FOR A DRY TEST STRIP - A dry test strip layer for filtering red blood cells includes a Borosilicate Glass Fiber layer and lectin, impregnated in the borosilicate layer, such that the dry test strip is configured to filter red blood cells from a blood sample. | 11-08-2012 |
Heather Twin US
Patent application number | Description | Published |
---|---|---|
20120136000 | TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 05-31-2012 |
Heather Twin, Denchworth GB
Patent application number | Description | Published |
---|---|---|
20090291937 | KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 11-26-2009 |
20120149680 | KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 06-14-2012 |
Heather Twin, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20130053395 | PYRAZOLOPYRIDINE KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 02-28-2013 |
20130252939 | TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 09-26-2013 |
Heather Twin, Wantage GB
Patent application number | Description | Published |
---|---|---|
20100190765 | DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 07-29-2010 |
20120071494 | PYRAZOLOPYRIDINE KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 03-22-2012 |
20120149898 | DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 06-14-2012 |
20140038935 | DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. | 02-06-2014 |
20140163000 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 06-12-2014 |
20140249157 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 09-04-2014 |
20140275009 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 09-18-2014 |
20140275021 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 09-18-2014 |
Heather Vander Ploeg, Scottsdale, AZ US
Patent application number | Description | Published |
---|---|---|
20120238913 | METHODS OF EVALUATING NORMALCY OF LIPS AND SAFETY OF LIP TREATMENTS - This disclosure relates to evaluating and objectively determining the relative normalcy of a human patient's lips, whether before or after a lip treatment, or independent from any lip treatment. The normalcy of a patient's lips is evaluated by examining a number of indicia and comparing the results to corresponding lip scales or reference descriptions. The normalcy may be evaluated before and after a lip treatment to determine the safety of the lip treatment. | 09-20-2012 |
Heather Welzant, Gambrills, MD US
Patent application number | Description | Published |
---|---|---|
20140188575 | COLLABORATIVE QUALITY ASSURANCE SYSTEM AND METHOD - The system and method for quality assurance (QA) of educational institutions, programs, courses, services, and processes stores a QA framework associated with an educational QA review in a database. The QA framework comprises one or more Quality Components (QCs) such that each QC is associated with one or more Quality Indicators (QI). Each QI is defined as a statement related to an educational quality attribute. A QI evaluation template is presented to one or more QA reviewers over a network for evaluating each QI. The QI evaluation template is used by the one or more QA reviewers for entry of one or more Observation Information (OI) for a QI under evaluation and associating each OI with respective evidence information and recommendation information (RI). The RI is then prioritized based on one or more evaluative metrics. | 07-03-2014 |
Heather Wighton, Flemington, NJ US
Patent application number | Description | Published |
---|---|---|
20120101817 | SYSTEM AND METHOD FOR GENERATING MODELS FOR USE IN AUTOMATIC SPEECH RECOGNITION - Disclosed herein are systems, methods, and non-transitory computer-readable storage media for generating a model for use with automatic speech recognition. These principles can be implemented as part of a streamlined tool for automatic training and tuning of speech, or other, models with a fast turnaround and with limited human involvement. A system configured to practice the method receives, as part of a request to generate a model, input data and a seed model. The system receives a cost function indicating accuracy and at least one of speed and memory usage, The system processes the input data based on seed model and based on parameters that optimize the cost function to yield an updated model, and outputs the updated model. | 04-26-2012 |
Heather Wilson-Robles, College Station, TX US
Patent application number | Description | Published |
---|---|---|
20120321666 | T CELL THERAPY FOR B CELL LYMPHOMA - Disclosed are methods and compositions for improving anti-tumor response and survivability in patients with cancer, such as non-Hodgkin lymphoma. In certain aspects, methods are provided for infusing lymphoma patients with T cells that are propagated ex vivo. Also provided are methods and compositions for propagating canine T cells ex vivo for infusion into cancer patients. | 12-20-2012 |